Mimicking CHO large‐scale effects in the single multicompartment bioreactor: A new approach to access scale‐up behavior
Biotechnology and Bioengineering · 2024-04 · 121 (4) · 1243-1255
DOI: 10.1002/bit.28647 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology and Bioengineering, online erschienen am 08.01.2024. Verfasst von Lena Gaugler und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biochemical Engineering, University of Stuttgart, Stuttgart, Germany. Hauptthemen laut MEDLINE: Batch Cell Culture Techniques, Bioreactors. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, German Research Foundation (DFG).
Abstract (Originalsprache)
During the scale‐up of biopharmaceutical production processes, insufficiently predictable performance losses may occur alongside gradients and heterogeneities. To overcome such performance losses, tools are required to explain, predict, and ultimately prohibit inconsistencies between laboratory and commercial scale. In this work, we performed CHO fed‐batch cultivations in the single multicompartment bioreactor (SMCB), a new scale‐down reactor system that offers new access to study large‐scale heterogeneities in mammalian cell cultures. At volumetric power inputs of 20.4–1.5 W m −3 , large‐scale characteristics like long mixing times and dissolved oxygen (DO) heterogeneities were mimicked in the SMCB. Compared to a reference bioreactor (REFB) set‐up, the conditions in the SMCB provoked an increase in lactate accumulation of up to 87%, an increased glucose uptake, and reduced viable cell concentrations in the stationary phase. All are characteristic for large‐scale performance. The unique possibility to distinguish between the effects of changing power inputs and observed heterogeneities provided new insights into the potential reasons for altered product quality attributes. Apparently, the degree of galactosylation in the evaluated glycan patterns changed primarily due to the different power inputs rather than the provoked heterogeneities. The SMCB system could serve as a potent tool to provide new insights into scale‐up behavior and to predict cell line‐specific drawbacks at an early stage of process development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biochemical Engineering, University of Stuttgart, Stuttgart, Germany.
- Institute of Multiphase Flows, Hamburg University of Technology, Hamburg, Germany.
ORCID-Profile: Lena Gaugler, Ralf Takors
Förderung
- Deutsche Forschungsgemeinschaft
- German Research Foundation (DFG)
Zitieren
APA
Gaugler, L., Hofmann, S., Schlüter, M., & Takors, R. (2024). Mimicking CHO large‐scale effects in the single multicompartment bioreactor: A new approach to access scale‐up behavior. Biotechnology and Bioengineering, 121(4), 1243-1255. https://doi.org/10.1002/bit.28647
Vancouver
Gaugler L, Hofmann S, Schlüter M, Takors R. Mimicking CHO large‐scale effects in the single multicompartment bioreactor: A new approach to access scale‐up behavior. Biotechnology and Bioengineering. 2024;121(4):1243-1255. doi:10.1002/bit.28647
BibTeX
@article{Gaugler2024,
author = {Gaugler, Lena and Hofmann, Sebastian and Schlüter, Michael and Takors, Ralf},
title = {Mimicking CHO large‐scale effects in the single multicompartment bioreactor: A new approach to access scale‐up behavior},
journal = {Biotechnology and Bioengineering},
year = {2024},
volume = {121},
number = {4},
pages = {1243--1255},
doi = {10.1002/bit.28647}
}
EUVIMED